Stroke in Heart Failure

References

• Engelhardt E. Apoplexy, cerebrovascular disease, and stroke: historical evolution of terms and definitions. Dement Neuropsychol. 2017;11(4):449–453. doi:10.1590/1980-57642016dn11-04001629354227
   PubMedGoogle Scholar
• Collaborators GN. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–480.30879893
   PubMed Web of Science ®Google Scholar
• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-916731270
   PubMed Web of Science ®Google Scholar
• Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602.27733282
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619. doi:10.1161/HHF.0b013e318291329a23616602
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Goldstein LB, Higashida RT, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44(8):2361–2375. doi:10.1161/STR.0b013e31829734f223697546
   PubMed Web of Science ®Google Scholar
• Witt BJ, Brown RD, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006;152(1):102–109. doi:10.1016/j.ahj.2005.10.01816824838
   PubMed Web of Science ®Google Scholar
• Lip GY, Rasmussen LH, Skjøth F, Overvad K, Larsen TB. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open. 2012;2(4):4. doi:10.1136/bmjopen-2012-000975
   Web of Science ®Google Scholar
• Kang SH, Kim J, Park JJ, et al. Risk of stroke in congestive heart failure with and without atrial fibrillation. Int J Cardiol. 2017;248:182–187. doi:10.1016/j.ijcard.2017.07.05628826798
   PubMed Web of Science ®Google Scholar
• Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006;37(7):1715–1719. doi:10.1161/01.STR.0000227121.34717.4016741172
   PubMed Web of Science ®Google Scholar
• Berger JS, Peterson E, LalibertÉ F, et al. Risk of ischemic stroke in patients newly diagnosed with heart failure: focus on patients without atrial fibrillation. J Card Fail. 2019;25(6):436–447. doi:10.1016/j.cardfail.2018.03.01229597052
   PubMed Web of Science ®Google Scholar
• Agarwal M, Apostolakis S, Lane DA, Lip GY. The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review. Clin Ther. 2014;36(9):1135–1144. doi:10.1016/j.clinthera.2014.07.01525146364
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA. 1983;250(21):2942–2946. doi:10.1001/jama.1983.033402100400226227757
   PubMed Web of Science ®Google Scholar
• Alberts VP, Bos MJ, Koudstaal P, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010;25(11):807–812. doi:10.1007/s10654-010-9520-y21061046
   PubMed Web of Science ®Google Scholar
• Abdul-Rahim AH, Perez AC, Fulton RL, et al. Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the Controlled Rosuvastatin in Multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure (GISSI-HF) trials. Circulation. 2015;131(17):1486–1494.25810334
   PubMed Web of Science ®Google Scholar
• Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol. 1999;33(5):1424–1426.10193748
   PubMed Web of Science ®Google Scholar
• Kalaria VG, Passannante MR, Shah T, Modi K, Weisse AB. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J. 1998;135(2):215–220. doi:10.1016/S0002-8703(98)70084-59489967
   PubMed Web of Science ®Google Scholar
• Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34(1):122–126. doi:10.1161/01.STR.0000047852.05842.3C12511762
   PubMed Web of Science ®Google Scholar
• Divani AA, Vazquez G, Asadollahi M, Qureshi AI, Pullicino P. Nationwide frequency and association of heart failure on stroke outcomes in the United States. J Card Fail. 2009;15(1):11–16. doi:10.1016/j.cardfail.2008.09.00119181288
   PubMed Web of Science ®Google Scholar
• Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015;314(10):1030–1038. doi:10.1001/jama.2015.1072526318604
   PubMed Web of Science ®Google Scholar
• Kumar G, Goyal MK. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials. J Stroke Cerebrovasc Dis. 2013;22(8):1279–1287. doi:10.1016/j.jstrokecerebrovasdis.2012.09.01523182364
   PubMed Web of Science ®Google Scholar